Downregulation of microRNA-146a inhibits ovarian granulosa cell apoptosis by simultaneously targeting interleukin-1 receptor-associated kinase and tumor necrosis factor receptor-associated factor 6

被引:53
作者
Chen, Xi [1 ]
Xie, Mingxuan [1 ]
Liu, Da [1 ]
Shi, Ke [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Geriatr Med, Changsha 410008, Hunan, Peoples R China
关键词
premature ovarian failure; microRNAs; microRNA-146a; interleukin-1 receptor-associated kinase; tumor necrosis factor receptor-associated factor 6; apoptosis; NF-KAPPA-B; MATURATION; IL-1-BETA; INDUCTION; FAILURE; RELEASE;
D O I
10.3892/mmr.2015.4036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Premature ovarian failure (POP), an ovarian disorder of multifactorial origin, is defined as the occurrence of amenorrhea, hypergonadotropism and hypoestrogenism in females <40 years old. Apoptosis of ovarian granulosa cells is important in POF and understanding the regulatory mechanism underlying ovarian granulosa cell apoptosis may be beneficial for the management of POF. Increasing evidence suggests that microRNAs (miRs) have a regulatory function in oocyte maturation and ovarian follicular development. In the present study, the expression of miR-146a in plasma and ovarian granulosa cells obtained from patients with POF, its effect on the apoptosis of ovarian granulosa cells and the possible underlying mechanisms were examined. The present study demonstrated that compared with the control groups, the expression of miR-146a in the plasma and in ovarian granulosa cells of patients with POF was significantly upregulated. Furthermore, it was found that miR-146a simultaneously targeted interleukin-1 receptor-associated kinase (IRAK1) and tumor necrosis factor receptor-associated factor 6 (TRAF6), which regulated the activity of nuclear factor-kappa B and I kappa B alpha. In addition, the results demonstrated that inhibition of the caspase cascade by caspase inhibitors attenuated the effects of miR-146a on ovarian granulosa cell apoptosis. Taken together, these results suggest that miR-146a has an important promoting effect on the apoptosis of granulosa cells by targeting IRAK1 and TRAF6 via the caspase cascade pathway. These results may be useful for the management of POF.
引用
收藏
页码:5155 / 5162
页数:8
相关论文
共 50 条
  • [41] MiR-590-3p Attenuates Acute Kidney Injury by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 in Septic Mice
    Ma, Jing
    Li, Yu-tao
    Zhang, Shi-xiong
    Fu, Shou-zhi
    Ye, Xian-zhi
    INFLAMMATION, 2019, 42 (02) : 637 - 649
  • [42] Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation
    Wicovsky, A.
    Henkler, F.
    Salzmann, S.
    Scheurich, P.
    Kneitz, C.
    Wajant, H.
    ONCOGENE, 2009, 28 (15) : 1769 - 1781
  • [43] A polymorphism in the 3′-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility
    Chatzikyriakidou, Anthoula
    Voulgari, Paraskevi V.
    Georgiou, Ioannis
    Drosos, Alexandros A.
    JOINT BONE SPINE, 2010, 77 (05) : 411 - 413
  • [44] Tumor Necrosis Factor Receptor-Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall
    Missiou, Anna
    Koestlin, Natascha
    Varo, Nerea
    Rudolf, Philipp
    Aichele, Peter
    Ernst, Sandra
    Muenkel, Christian
    Walter, Carina
    Stachon, Peter
    Sommer, Benjamin
    Pfeifer, Dietmar
    Zirlik, Katja
    MacFarlane, Lindsey
    Wolf, Dennis
    Tsitsikov, Erdyni
    Bode, Christoph
    Libby, Peter
    Zirlik, Andreas
    CIRCULATION, 2010, 121 (18) : 2033 - 2044
  • [45] Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity
    Watany, Mona M.
    Elhosary, Marwa M.
    El-Horany, Hemat E.
    El-Horany, Mahmoud E.
    CLINICAL IMMUNOLOGY, 2024, 266
  • [46] Intracellular localization and transcriptional regulation of tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4)
    Glauner, H
    Siegmund, D
    Motejadded, H
    Scheurich, P
    Henkler, F
    Janssen, O
    Wajant, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (19): : 4819 - 4829
  • [47] Expression of Interleukin-1 Receptor-Associated Kinase-1 in Non-Small Cell Lung Carcinoma and Preneoplastic Lesions
    Behrens, Carmen
    Feng, Lei
    Kadara, Humam
    Kim, Hyun-Jung
    Lee, J. Jack
    Mehran, Reza
    Hong, Waun Ki
    Lotan, Reuben
    Wistuba, Ignacio I.
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 34 - 44
  • [48] Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor B (RANK) Signaling Complex Enhances Osteoclastogenesis
    Yu, Jiyeon
    Yun, Hyeongseok
    Shin, Bongjin
    Kim, Yongjin
    Park, Eui-Soon
    Choi, Seunga
    Yu, Jungeun
    Amarasekara, Dulshara Sachini
    Kim, Sumi
    Inoue, Jun-ichiro
    Walsh, Matthew C.
    Choi, Yongwon
    Takami, Masamichi
    Rho, Jaerang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (39) : 20643 - 20660
  • [49] Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B
    VanArsdale, TL
    VanArsdale, SL
    Force, WR
    Walter, BN
    Mosialos, G
    Kieff, E
    Reed, JC
    Ware, CF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2460 - 2465
  • [50] Tumor Necrosis Factor Receptor-associated Factor 1 influences KRN/I-Ag7 Mouse Arthritis Autoantibody Production
    Cheng, Tao
    Choi, Yongwon
    Finkel, Terri H.
    Tsao, Patricia Y.
    Ji, Mei Qing
    Eisenberg, Robert A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 (04) : 759 - 766